- Home
- ELVN vs RLJ Comparison
ELVN vs RLJ Comparison
Compare ELVN & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- RLJ
- Stock Information
- Founded
- ELVN 2016
- RLJ 2011
- Country
- ELVN United States
- RLJ United States
- Employees
- ELVN N/A
- RLJ N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- RLJ Real Estate Investment Trusts
- Sector
- ELVN Health Care
- RLJ Real Estate
- Exchange
- ELVN Nasdaq
- RLJ Nasdaq
- Market Cap
- ELVN 1.2B
- RLJ 1.1B
- IPO Year
- ELVN 2020
- RLJ 2011
- Fundamental
- Price
- ELVN $19.02
- RLJ $7.62
- Analyst Decision
- ELVN Strong Buy
- RLJ Hold
- Analyst Count
- ELVN 5
- RLJ 6
- Target Price
- ELVN $41.20
- RLJ $9.55
- AVG Volume (30 Days)
- ELVN 489.5K
- RLJ 2.2M
- Earning Date
- ELVN 11-12-2025
- RLJ 11-05-2025
- Dividend Yield
- ELVN N/A
- RLJ 7.91%
- EPS Growth
- ELVN N/A
- RLJ N/A
- EPS
- ELVN N/A
- RLJ 0.20
- Revenue
- ELVN N/A
- RLJ $1,367,020,000.00
- Revenue This Year
- ELVN N/A
- RLJ $0.37
- Revenue Next Year
- ELVN $20.05
- RLJ $1.67
- P/E Ratio
- ELVN N/A
- RLJ $38.10
- Revenue Growth
- ELVN N/A
- RLJ 1.40
- 52 Week Low
- ELVN $13.30
- RLJ $6.16
- 52 Week High
- ELVN $30.03
- RLJ $10.84
- Technical
- Relative Strength Index (RSI)
- ELVN 44.06
- RLJ 51.05
- Support Level
- ELVN $18.01
- RLJ $7.43
- Resistance Level
- ELVN $20.30
- RLJ $7.76
- Average True Range (ATR)
- ELVN 1.11
- RLJ 0.17
- MACD
- ELVN -0.16
- RLJ -0.02
- Stochastic Oscillator
- ELVN 30.70
- RLJ 29.37
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value
RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.